AJP - Renal Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 258: F1232-F1236, 1990;
0363-6127/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stacy, D. L.
Right arrow Articles by Granger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stacy, D. L.
Right arrow Articles by Granger, J. P.

AJP - Renal Physiology, Vol 258, Issue 5 1232-F1236, Copyright © 1990 by American Physiological Society

ARTICLES

Control of renal function during intrarenal infusion of endothelin

D. L. Stacy, J. W. Scott and J. P. Granger
Department of Physiology, Eastern Virginia Medical School, Norfolk 23501.

It has been demonstrated that bolus injections of a vasoconstrictor derived from endothelial cells, endothelin 1 (ET-1), constricts isolated arteries and increases blood pressure in animals when infused intravenously. The purpose of this study was to examine the direct effects of intrarenal infusions of ET-1 on renal function at doses that do not alter systemic arterial pressure. The effects of ET-1 on renal hemodynamics and electrolyte excretion were examined during 40 min of intrarenal infusions of ET-1 at rates of 1.15 and 5 ng.kg-1.min-1. Infusion of ET-1 (1.15 ng.kg-1.min-1) resulted in a transient increase in renal blood flow (RBF) followed by a progressive vasoconstriction, which reduced RBF by 23%. ET-1 decreased glomerular filtration rate (GFR) and had no significant effect on filtration fraction. Intrarenal infusion of ET-1 (1.15 ng.kg-1.min-1) had no effect on fractional excretion of sodium (FENa) or potassium. Infusion of ET-1 at a higher dose (5 ng.kg-1.min-1) produced further reductions in RBF, GFR, and FENa. These data indicate that ET-1 is a potent renal vasoconstrictor that could play a role in controlling renal hemodynamics.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Z. Abassi, B. Bishara, T. Karram, S. Khatib, J. Winaver, and A. Hoffman
Adverse effects of pneumoperitoneum on renal function: involvement of the endothelin and nitric oxide systems
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R842 - R850.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. Hoffman, Z. A. Abassi, S. Brodsky, R. Ramadan, and J. Winaver
Mechanisms of Big Endothelin-1-Induced Diuresis and Natriuresis : Role of ETB Receptors
Hypertension, March 1, 2000; 35(3): 732 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Berthold, K. Munter, A. Just, H. R. Kirchheim, and H. Ehmke
Contribution of endothelin to renal vascular tone and autoregulation in the conscious dog
Am J Physiol Renal Physiol, March 1, 1999; 276(3): F417 - F424.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. Lin, M. J. Smith, and D. B. Young
Roles of Prostaglandins and Nitric Oxide in the Effect of Endothelin-1 on Renal Hemodynamics
Hypertension, September 1, 1996; 28(3): 372 - 378.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online